The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective clinical phase-II trial on docetaxel and estramustine with or without epoeitin-α in patients with metastatic castration-resistant prostate cancer (mCRPC).
 
Axel Heidenreich
Honoraria - Astellas Pharma; Bayer Schering Pharma; Dendreon; Ferring; Ipsen; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; Ferring; Ipsen; Janssen; Pfizer; Sanofi; Takeda
Research Funding - Astellas Pharma (Inst); Sanofi
 
Kurt Miller
Honoraria - Astellas Pharma; Dendreon; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Bayer; Dendreon; Ipsen; Janssen; Sanofi; Takeda
Speakers' Bureau - Astellas Pharma; Bayer; Ferring; Ipsen; Janssen; Sanofi; Takeda
 
Ursula Steiner
No Relationships to Disclose
 
Martin Schostak
Honoraria - EDAP TMS; Sanofi; Takeda
Speakers' Bureau - Astellas Pharma; EDAP TMS; Sanofi; Takeda